Dermatology · Santa Clara, CA
NPI
1124283056
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
710 Lawrence Expy, Dermatology, Dept 472
Santa Clara, CA, 95051
Phone (408) 851-4650
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$436K
763 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Melvin Lee prescribed most often to Medicare patients was Clobetasol Propionate, with 161 prescriptions and refills. In total Melvin Lee wrote 763 Medicare prescriptions that cost $436K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 161 | 165 | 57 | $4,303 |
| Tacrolimus Generic | 73 | 75 | 24 | $5,842 |
| Triamcinolone Acetonide Generic | 73 | 75 | 43 | $1,354 |
| Fluorouracil Generic | 55 | 55 | 48 | $2,091 |
| Hydrocortisone Generic | 51 | 51 | 30 | $680 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 45 | 45 | 11 | $2,706 |
| Vectical Calcitriol | 38 | 49 | 16 | $7,141 |
| Calcipotriene Generic | 31 | 33 | 18 | $4,335 |
| Metronidazole Generic | 28 | 28 | 11 | $544 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 26 | 26 | Under 11 | $85K |
| Methotrexate Methotrexate Sodium | 16 | 32 | Under 11 | $229 |
| Fluocinonide Generic | 15 | 15 | Under 11 | $396 |
| Cosentyx (2 Syringes) Secukinumab | 14 | 14 | Under 11 | $55K |
| Mupirocin Generic | 12 | 12 | Under 11 | $139 |
| Cordran Flurandrenolide | 12 | 12 | Under 11 | $9,533 |
Brand drugs: 120 claims; generic drugs: 643 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Melvin Lee were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.